Clinical Trial Update: Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern [Phase 2, Phase 3]

View source ↗

Summary

This report summarizes efficacy results from a Phase 2/3 study of a COVID-19 mRNA vaccine in regions with SARS-CoV-2 variants of concern. Results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• COVID-19 mRNA vaccine

Snippet

Sponsor: COVID-19 Prevention Network | Conditions: SARS-CoV-2 Infection, HIV Infections | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-11-26